Higher doses are not associated with a safety risk, the FDA said Nov. 1, and no serious adverse effects have been reported.
“[The] FDA has become aware that some healthcare providers may not recognize that the single dose vial of Moderna COVID-19 Vaccine (2023-2024 Formula) for use in individuals 6 months through 11 years of age contains notably more than 0.25 mL of the vaccine,” the Nov. 1 warning said. “Some healthcare providers may be withdrawing the entire contents of the vial to administer to an individual” even though the approved dosage is 0.25 milliliters.
Excess solution from the vial should be discarded, the agency said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
